Global Veterinary Oncology Market By Animal Type (Canine, Feline, and Others), By Treatment Type (Immunotherapy, Radiotherapy, Surgery, Chemotherapy, and Other Treatment Types), By Application (Skin Cancers, Lymphomas, Sarcomas, Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: Jan 2025
Report ID: 137101
Number of Pages: 373
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Veterinary Oncology Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Veterinary Oncology Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Veterinary Oncology Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 3.3. Global Veterinary Oncology Market Attractiveness Analysis, By Animal Type
    
    3.3.1. Canine
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Feline
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Others
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
  - 3.4. Global Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.5. Global Veterinary Oncology Market Attractiveness Analysis, By Application
    
    3.5.1. Skin Cancers
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Lymphomas
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Sarcomas
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Others
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 3.7. Global Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
    
    3.7.1. Immunotherapy
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Radiotherapy
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Surgery
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Chemotherapy
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
    
    3.7.5. Other Treatment Types
    
    3.7.5.1. Insights
    
    3.7.5.2. Key Takeaways
- 4. Global Veterinary Oncology Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Veterinary Oncology Market Attractiveness Analysis, By Region
- 5. North America Veterinary Oncology Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 5.3. North America Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - 5.4. North America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.5. North America Veterinary Oncology Market Attractiveness Analysis, By Application
  - 5.6. North America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 5.7. North America Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - 5.8. North America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Veterinary Oncology Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Veterinary Oncology Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 6.3. Europe Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - 6.4. Europe Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.5. Europe Veterinary Oncology Market Attractiveness Analysis, By Application
  - 6.6. Europe Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 6.7. Europe Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - 6.8. Europe Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Veterinary Oncology Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Veterinary Oncology Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 7.3. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - 7.4. Asia Pacific Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.5. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 7.7. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - 7.8. Asia Pacific Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Veterinary Oncology Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 8.3. Latin America Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - 8.4. Latin America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.5. Latin America Veterinary Oncology Market Attractiveness Analysis, By Application
  - 8.6. Latin America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 8.7. Latin America Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - 8.8. Latin America Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Veterinary Oncology Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Veterinary Oncology Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 9.3. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - 9.4. Middle East & Africa Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.5. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 9.7. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - 9.8. Middle East & Africa Veterinary Oncology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Elanco
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Boehringer Ingelheim International GmbH
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Zoetis
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Elekta AB
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. PetCure Oncology
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Accuray Incorporated
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Varian Medical Systems, Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Merck & Co., Inc.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Dechra Pharmaceuticals PLC
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. NovaVive Inc.
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Ardent Animal Health, LLC
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 2. Global Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 3. Global Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 4. Global Veterinary Oncology Market Value (US$ Mn), By Region, 2020-2034
  - Table 5. North America Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 6. North America Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 7. North America Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 8. North America Veterinary Oncology Market Value (US$ Mn), By Country, 2020-2034
  - Table 9. The US Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 10. The US Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 11. The US Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 12. Canada Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 13. Canada Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 14. Canada Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 15. Europe Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 16. Europe Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 17. Europe Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 18. Europe Veterinary Oncology Market Value (US$ Mn), By Country, 2020-2034
  - Table 19. Germany Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 20. Germany Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 21. Germany Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 22. The UK Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 23. The UK Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 24. The UK Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 25. France Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 26. France Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 27. France Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 28. Spain Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 29. Spain Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 30. Spain Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 31. Italy Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 32. Italy Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 33. Italy Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 34. Russia Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 35. Russia Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 36. Russia Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 37. Netherland Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 38. Netherland Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 39. Netherland Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 40. Rest of Europe Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 41. Rest of Europe Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 42. Rest of Europe Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 43. Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 44. Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 45. Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 46. Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Country, 2020-2034
  - Table 47. China Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 48. China Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 49. China Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 50. India Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 51. India Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 52. India Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 53. Japan Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 54. Japan Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 55. Japan Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 56. South Korea Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 57. South Korea Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 58. South Korea Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 59. Australia Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 60. Australia Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 61. Australia Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 62. New Zealand Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 63. New Zealand Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 64. New Zealand Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 65. Singapore Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 66. Singapore Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 67. Singapore Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 68. Thailand Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 69. Thailand Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 70. Thailand Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 71. Vietnam Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 72. Vietnam Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 73. Vietnam Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 74. Rest of Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 75. Rest of Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 76. Rest of Asia Pacific Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 77. Latin America Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 78. Latin America Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 79. Latin America Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 80. Latin America Veterinary Oncology Market Value (US$ Mn), By Country, 2020-2034
  - Table 81. Brazil Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 82. Brazil Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 83. Brazil Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 84. Mexico Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 85. Mexico Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 86. Mexico Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 87. Rest of Latin America Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 88. Rest of Latin America Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 89. Rest of Latin America Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 90. Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 91. Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 92. Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 93. Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Country, 2020-2034
  - Table 94. South Africa Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 95. South Africa Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 96. South Africa Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 97. Saudi Arabia Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 98. Saudi Arabia Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 99. Saudi Arabia Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 100. UAE Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 101. UAE Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 102. UAE Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
  - Table 103. Rest of Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 104. Rest of Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Application, 2020-2034
  - Table 105. Rest of Middle East & Africa Veterinary Oncology Market Value (US$ Mn), By Treatment Type, 2020-2034
- List of Figures
  - Figure 1. Global Veterinary Oncology Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Veterinary Oncology Market
  - Figure 5. Global Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 6. Global Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 7. Global Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 8. Global Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 9. Global Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 10. Global Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 11. Global Veterinary Oncology Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 12. Global Veterinary Oncology Market Attractiveness Analysis, By Region
  - Figure 13. North America Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 14. North America Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 15. North America Veterinary Oncology Market (US$ Mn), by Canine, 2020-2034
  - Figure 16. North America Veterinary Oncology Market (US$ Mn), by Feline, 2020-2034
  - Figure 17. North America Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 18. North America Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 19. North America Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 20. North America Veterinary Oncology Market (US$ Mn), by Skin Cancers, 2020-2034
  - Figure 21. North America Veterinary Oncology Market (US$ Mn), by Lymphomas, 2020-2034
  - Figure 22. North America Veterinary Oncology Market (US$ Mn), by Sarcomas, 2020-2034
  - Figure 23. North America Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 24. North America Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 25. North America Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 26. North America Veterinary Oncology Market (US$ Mn), by Immunotherapy, 2020-2034
  - Figure 27. North America Veterinary Oncology Market (US$ Mn), by Radiotherapy, 2020-2034
  - Figure 28. North America Veterinary Oncology Market (US$ Mn), by Surgery, 2020-2034
  - Figure 29. North America Veterinary Oncology Market (US$ Mn), by Chemotherapy, 2020-2034
  - Figure 30. North America Veterinary Oncology Market (US$ Mn), by Other Treatment Types, 2020-2034
  - Figure 31. North America Veterinary Oncology Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 32. North America Veterinary Oncology Market Attractiveness Analysis, By Country
  - Figure 33. Europe Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 34. Europe Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 35. Europe Veterinary Oncology Market (US$ Mn), by Canine, 2020-2034
  - Figure 36. Europe Veterinary Oncology Market (US$ Mn), by Feline, 2020-2034
  - Figure 37. Europe Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 38. Europe Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 39. Europe Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 40. Europe Veterinary Oncology Market (US$ Mn), by Skin Cancers, 2020-2034
  - Figure 41. Europe Veterinary Oncology Market (US$ Mn), by Lymphomas, 2020-2034
  - Figure 42. Europe Veterinary Oncology Market (US$ Mn), by Sarcomas, 2020-2034
  - Figure 43. Europe Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 44. Europe Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 45. Europe Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 46. Europe Veterinary Oncology Market (US$ Mn), by Immunotherapy, 2020-2034
  - Figure 47. Europe Veterinary Oncology Market (US$ Mn), by Radiotherapy, 2020-2034
  - Figure 48. Europe Veterinary Oncology Market (US$ Mn), by Surgery, 2020-2034
  - Figure 49. Europe Veterinary Oncology Market (US$ Mn), by Chemotherapy, 2020-2034
  - Figure 50. Europe Veterinary Oncology Market (US$ Mn), by Other Treatment Types, 2020-2034
  - Figure 51. Europe Veterinary Oncology Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 52. Europe Veterinary Oncology Market Attractiveness Analysis, By Country
  - Figure 53. Asia Pacific Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 54. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 55. Asia Pacific Veterinary Oncology Market (US$ Mn), by Canine, 2020-2034
  - Figure 56. Asia Pacific Veterinary Oncology Market (US$ Mn), by Feline, 2020-2034
  - Figure 57. Asia Pacific Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 58. Asia Pacific Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 59. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 60. Asia Pacific Veterinary Oncology Market (US$ Mn), by Skin Cancers, 2020-2034
  - Figure 61. Asia Pacific Veterinary Oncology Market (US$ Mn), by Lymphomas, 2020-2034
  - Figure 62. Asia Pacific Veterinary Oncology Market (US$ Mn), by Sarcomas, 2020-2034
  - Figure 63. Asia Pacific Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 64. Asia Pacific Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 65. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 66. Asia Pacific Veterinary Oncology Market (US$ Mn), by Immunotherapy, 2020-2034
  - Figure 67. Asia Pacific Veterinary Oncology Market (US$ Mn), by Radiotherapy, 2020-2034
  - Figure 68. Asia Pacific Veterinary Oncology Market (US$ Mn), by Surgery, 2020-2034
  - Figure 69. Asia Pacific Veterinary Oncology Market (US$ Mn), by Chemotherapy, 2020-2034
  - Figure 70. Asia Pacific Veterinary Oncology Market (US$ Mn), by Other Treatment Types, 2020-2034
  - Figure 71. Asia Pacific Veterinary Oncology Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 72. Asia Pacific Veterinary Oncology Market Attractiveness Analysis, By Country
  - Figure 73. Latin America Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 74. Latin America Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 75. Latin America Veterinary Oncology Market (US$ Mn), by Canine, 2020-2034
  - Figure 76. Latin America Veterinary Oncology Market (US$ Mn), by Feline, 2020-2034
  - Figure 77. Latin America Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 78. Latin America Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 79. Latin America Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 80. Latin America Veterinary Oncology Market (US$ Mn), by Skin Cancers, 2020-2034
  - Figure 81. Latin America Veterinary Oncology Market (US$ Mn), by Lymphomas, 2020-2034
  - Figure 82. Latin America Veterinary Oncology Market (US$ Mn), by Sarcomas, 2020-2034
  - Figure 83. Latin America Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 84. Latin America Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 85. Latin America Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 86. Latin America Veterinary Oncology Market (US$ Mn), by Immunotherapy, 2020-2034
  - Figure 87. Latin America Veterinary Oncology Market (US$ Mn), by Radiotherapy, 2020-2034
  - Figure 88. Latin America Veterinary Oncology Market (US$ Mn), by Surgery, 2020-2034
  - Figure 89. Latin America Veterinary Oncology Market (US$ Mn), by Chemotherapy, 2020-2034
  - Figure 90. Latin America Veterinary Oncology Market (US$ Mn), by Other Treatment Types, 2020-2034
  - Figure 91. Latin America Veterinary Oncology Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 92. Latin America Veterinary Oncology Market Attractiveness Analysis, By Country
  - Figure 93. Middle East & Africa Veterinary Oncology Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 94. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Animal Type
  - Figure 95. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Canine, 2020-2034
  - Figure 96. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Feline, 2020-2034
  - Figure 97. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 98. Middle East & Africa Veterinary Oncology Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 99. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Application
  - Figure 100. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Skin Cancers, 2020-2034
  - Figure 101. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Lymphomas, 2020-2034
  - Figure 102. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Sarcomas, 2020-2034
  - Figure 103. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Others, 2020-2034
  - Figure 104. Middle East & Africa Veterinary Oncology Market Analysis, By Treatment Type, 2020, 2024 and 2034
  - Figure 105. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Treatment Type
  - Figure 106. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Immunotherapy, 2020-2034
  - Figure 107. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Radiotherapy, 2020-2034
  - Figure 108. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Surgery, 2020-2034
  - Figure 109. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Chemotherapy, 2020-2034
  - Figure 110. Middle East & Africa Veterinary Oncology Market (US$ Mn), by Other Treatment Types, 2020-2034
  - Figure 111. Middle East & Africa Veterinary Oncology Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 112. Middle East & Africa Veterinary Oncology Market Attractiveness Analysis, By Country
- Elanco
- Boehringer Ingelheim International GmbH
- Zoetis
- Elekta AB
- PetCure Oncology
- Accuray Incorporated
- Varian Medical Systems, Inc.
- Virbac
- Merck & Co., Inc.
- Dechra Pharmaceuticals PLC
- NovaVive Inc.
- Ardent Animal Health, LLC
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 137101
Published Date Jan 2025
Rating
- ★★★★★
  
  ★★★★★
- (142)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)